Provided by Tiger Fintech (Singapore) Pte. Ltd.

Esperion Therapeutics

2.66
-0.0900-3.27%
Post-market: 2.690.0300+1.13%19:39 EDT
Volume:10.73M
Turnover:29.62M
Market Cap:536.32M
PE:-5.01
High:2.94
Open:2.83
Low:2.65
Close:2.75
52wk High:3.94
52wk Low:0.6925
Shares:201.62M
Float Shares:199.76M
Volume Ratio:2.05
T/O Rate:5.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5305
EPS(LYR):-0.2764
ROE:97.76%
ROA:-6.34%
PB:-1.24
PE(LYR):-9.62

Loading ...

Apr 02, 2025

Major Issues Report

Form 8-K - Current report
Mar 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 18, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 07, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 04, 2025

Major Issues Report

Form 8-K - Current report
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 16, 2025

Major Issues Report

Form 8-K - Current report
Dec 18, 2024

Major Issues Report

Form 8-K - Current report
Dec 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 07, 2024

Major Issues Report

Form 8-K - Current report